je.st
news
Tag: drug
FDA OKs breakthrough cholesterol drug for high-risk patients
2015-07-24 21:19:33| Biotech - Topix.net
" The Food and Drug Administration says it has approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. The drug from Sanofi and Regeneron Pharmaceuticals Inc. offers an important new option for millions of patients at high risk of heart disease.
Tags: drug
patients
cholesterol
breakthrough
EU drug regulator recommends 1st license for malaria shot
2015-07-24 14:00:19| Biotech - Topix.net
In this Oct. 30, 2009 file photo, a mother holds her baby as she receives a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya. The European Medicines Agency is recommending that the world's leading malaria vaccine be licensed even though it is only about 30 percent effective and that protection fades over time.
Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis
2015-07-23 21:20:21| Biotech - Topix.net
Amgen today announced the submission of a supplemental New Drug Application to the U.S. Food and Drug Administration for Kyprolis for Injection to seek an expanded indication for the treatment of patients with a form of blood cancer, relapsed multiple myeloma, who have received at least one prior therapy. Kyprolis currently has accelerated approval in the U.S. for the treatment of patients with relapsed multiple myeloma as a monotherapy.
Tags: application
drug
submission
announces
Surging new drug sales highlight strong Bristol-Myers Q2
2015-07-23 16:20:43| Biotech - Topix.net
Surging sales for new cancer, heart and hepatitis C medicines helped drugmaker Bristol-Myers Squibb Co. beat Wall Street expectations, and it boosted its 2015 profit forecast.
Tags: sales
strong
drug
highlight
Investor delighted to support cancer drug project
2015-07-23 14:13:36| Biotech - Topix.net
FUND manager Woodford Investment Management, based in Oxford, is one of several new investors in Immunocure as a result of the biotechnology firm's A 205m private financing round. The company said it would use the proceeds to accelerate its pipeline of biological drugs, which it calls ImmTACs, and which the biotech firm believes have the potential to treat solid cancer tumours.
Tags: support
project
drug
cancer
Sites : [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] next »